Advanced Material Processing (AMP) and Automated Handling Solutions (AHS), have announced their merger and rebranding as Akona Process Solutions (Akona), a portfolio company of Chicago-based, May River Capital.
ITM has announced positive topline results from its Phase 3 COMPETE trial in patients with inoperable, progressive Grade 1 or Grade 2 gastroenteropancreatic neuroendocrine tumours (GEP-NETs).
PHARMAP invites industry professionals to find new business partners, showcase equipment and services to potential customers, as well as enjoy networking and celebrate the 5th anniversary. The Congress takes place in Berlin, Germany, on 14-15 April.
Patent-filing research conducted by Withers & Rogers suggests that CAR T-cell therapy capability has reached a pivotal point on route to market, and first-line use of these promising treatments for various forms of cancer is nearing.
Cold Chain Technologies (CCT) and Tower Cold Chain, a subsidiary of CCT, have reached important milestones in their ongoing commitment to sustainability.
A cobot solution from FANUC and system integrator SKDK is alleviating health and safety issues at Takeda Pharmaceutical Company by working collaboratively with human employees to pack and stack packets of tablets onto pallets.
Tecan has announced the unveiling of Veya, a transformative liquid handling platform designed to bring efficiency, precision and compliance to laboratories of all sizes.
Clinigen has announced a strategic partnership with Tepsivo, a pioneering global digital Pharmacovigilance (PV) services provider. As part of the partnership, Clinigen has acquired a minority stake in Tepsivo.
Cancer Research Horizons has joined Lifebit’s Federated Data Network to help maximise the impact of data generated through Cancer Research UK-funded research.
After Merck announced the launch of a beta version of M-Trust™, a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting, EPM asked some follow-ups questions to learn more.
